PE20060303A1 - Metabolitos de indolilalquilamina como ligandos de 5-hidroxitriptamina-6 - Google Patents
Metabolitos de indolilalquilamina como ligandos de 5-hidroxitriptamina-6Info
- Publication number
- PE20060303A1 PE20060303A1 PE2005000696A PE2005000696A PE20060303A1 PE 20060303 A1 PE20060303 A1 PE 20060303A1 PE 2005000696 A PE2005000696 A PE 2005000696A PE 2005000696 A PE2005000696 A PE 2005000696A PE 20060303 A1 PE20060303 A1 PE 20060303A1
- Authority
- PE
- Peru
- Prior art keywords
- chloroimidazo
- thiazol
- indol
- alkyl
- hydroxitriptamine
- Prior art date
Links
- 239000011230 binding agent Substances 0.000 title abstract 2
- 239000002207 metabolite Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 abstract 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Natural products CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 abstract 2
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical compound O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 abstract 2
- 208000019901 Anxiety disease Diseases 0.000 abstract 1
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 abstract 1
- 208000019430 Motor disease Diseases 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 230000036506 anxiety Effects 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
- C07H7/02—Acyclic radicals
- C07H7/033—Uronic acids
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Saccharide Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
SE REFIERE A UN COMPUESTO DE FORMULA I, DONDE Q ES CO2R5, CH2NR6COR7; R1 ES H, ALQUILO C1-C6; R2 ES ARILO, HETEROARILO SUSTITUIDO O NO POR UN ANILLO BICICLICO O TRICICLICO DE 8-13 MIEMBROS QUE POSEE UN ATOMO DE N EN LA CABEZA DE PUENTE; R3 Y R4 SON CADA UNO H, HALOGENO, CN, ENTRE OTROS; R5 Y R6 SON CADA UNO H, ALQUILO C3-C6; R7 ES ALQUILO C1-C6. SON COMPUESTOS PREFERIDOS: N-(2-{1-[(6-CLOROIMIDAZO[2,1-b][1,3]TIAZOL-5-IL)SULFONIL]-1H-INDOL-3-IL}ETIL)ACETAMIDA; ACIDO 1-O-{[(2-{1-[(6-CLOROIMIDAZO[2,1-b][1,3]TIAZOL-5-IL)SULFONIL]-1H-INDOL-3-IL}ETIL)AMINO]CARBONIL}-BETA-D-GLUCOPIRANURONICO; ACIDO {1-[(6-CLOROIMIDAZO[2,1-b][1,3]TIAZOL-5-IL)SULFONIL]-1H-INDOL-3-IL}ACETICO. SE REFIERE TAMBIEN A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS SON LIGANDOS DE 5-HIDROXITRIPTAMINA-6 (5-HT6), UTILES EN EL TRATAMIENTO DE TRASTORNOS DEL SNC TALES COMO ANSIEDAD, DEPRESION, TRASTORNOS MOTORES, ENTRE OTROS
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US58229004P | 2004-06-23 | 2004-06-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20060303A1 true PE20060303A1 (es) | 2006-05-19 |
Family
ID=35033547
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2005000696A PE20060303A1 (es) | 2004-06-23 | 2005-06-17 | Metabolitos de indolilalquilamina como ligandos de 5-hidroxitriptamina-6 |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US7498327B2 (es) |
| EP (1) | EP1758898A1 (es) |
| JP (1) | JP2008504267A (es) |
| KR (1) | KR20070041514A (es) |
| CN (1) | CN1976928A (es) |
| AR (1) | AR049449A1 (es) |
| AU (1) | AU2005258025A1 (es) |
| BR (1) | BRPI0512540A (es) |
| CA (1) | CA2570818A1 (es) |
| CR (1) | CR8825A (es) |
| EC (1) | ECSP067096A (es) |
| IL (1) | IL180198A0 (es) |
| MX (1) | MX2007000182A (es) |
| NO (1) | NO20070065L (es) |
| PA (1) | PA8637801A1 (es) |
| PE (1) | PE20060303A1 (es) |
| RU (1) | RU2006146923A (es) |
| TW (1) | TW200606148A (es) |
| WO (1) | WO2006002125A1 (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7635710B2 (en) * | 2006-02-15 | 2009-12-22 | Neurim Pharmaceuticals (1991) Ltd. | Pyrone-indole derivatives and process for their preparation |
| US9101613B2 (en) | 2006-02-15 | 2015-08-11 | Neurim Pharmaceuticals (1991) Ltd. | Methods for treating neurological disease |
| EP1953153A1 (en) * | 2007-01-31 | 2008-08-06 | Laboratorios del Dr. Esteve S.A. | Heterocyclyl-substituted sulfonamides for the treatment of cognitive or food ingestion related disorders |
| EP2053052A1 (en) | 2007-10-23 | 2009-04-29 | Laboratorios del Dr. Esteve S.A. | Process for the preparation of 6-substituted imidazo[2,1-b]thiazole-5-sulfonyl halide |
| WO2015090233A1 (en) | 2013-12-20 | 2015-06-25 | Sunshine Lake Pharma Co., Ltd. | Aromatic heterocyclic compounds and their application in pharmaceuticals |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3489767A (en) * | 1966-01-12 | 1970-01-13 | Sumitomo Chemical Co | 1-(phenylsulfonyl)-3-indolyl aliphatic acid derivatives |
| GB9820113D0 (en) * | 1998-09-15 | 1998-11-11 | Merck Sharp & Dohme | Therapeutic agents |
| US6380166B1 (en) | 1999-09-13 | 2002-04-30 | American Home Products Corporation | Glucopyranosides conjugates of 2-(4-hydroxy-phenyl)-3-methyl-1-[4-(2-amin-1-yl-ethoxy)-benzyl]-1H-indol-5-ols |
| EP1455779B1 (en) * | 2001-12-20 | 2006-08-09 | Wyeth | Indolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands |
| EP1600440A1 (en) * | 2003-03-06 | 2005-11-30 | Ono Pharmaceutical Co., Ltd. | Indole derivative compounds and drugs containing the compounds as the active ingredient |
| US7202266B2 (en) * | 2003-07-17 | 2007-04-10 | Plexxikon, Inc. | PPAR active compounds |
| WO2005040112A1 (en) * | 2003-10-14 | 2005-05-06 | Oxagen Limited | Compounds with pgd2 antagonist activity |
-
2005
- 2005-06-17 PE PE2005000696A patent/PE20060303A1/es not_active Application Discontinuation
- 2005-06-21 EP EP05766100A patent/EP1758898A1/en not_active Withdrawn
- 2005-06-21 CA CA002570818A patent/CA2570818A1/en not_active Abandoned
- 2005-06-21 BR BRPI0512540-5A patent/BRPI0512540A/pt not_active IP Right Cessation
- 2005-06-21 WO PCT/US2005/021852 patent/WO2006002125A1/en active Application Filing
- 2005-06-21 AU AU2005258025A patent/AU2005258025A1/en not_active Abandoned
- 2005-06-21 JP JP2007518190A patent/JP2008504267A/ja not_active Withdrawn
- 2005-06-21 MX MX2007000182A patent/MX2007000182A/es active IP Right Grant
- 2005-06-21 CN CNA2005800206836A patent/CN1976928A/zh active Pending
- 2005-06-21 AR ARP050102544A patent/AR049449A1/es unknown
- 2005-06-21 KR KR1020077000822A patent/KR20070041514A/ko not_active Withdrawn
- 2005-06-21 RU RU2006146923/04A patent/RU2006146923A/ru not_active Application Discontinuation
- 2005-06-21 TW TW094120536A patent/TW200606148A/zh unknown
- 2005-06-22 US US11/158,702 patent/US7498327B2/en not_active Expired - Fee Related
- 2005-06-23 PA PA20058637801A patent/PA8637801A1/es unknown
-
2006
- 2006-12-19 IL IL180198A patent/IL180198A0/en unknown
- 2006-12-19 EC EC2006007096A patent/ECSP067096A/es unknown
- 2006-12-21 CR CR8825A patent/CR8825A/es not_active Application Discontinuation
-
2007
- 2007-01-04 NO NO20070065A patent/NO20070065L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1976928A (zh) | 2007-06-06 |
| WO2006002125A1 (en) | 2006-01-05 |
| KR20070041514A (ko) | 2007-04-18 |
| CR8825A (es) | 2007-08-28 |
| AR049449A1 (es) | 2006-08-02 |
| CA2570818A1 (en) | 2006-01-05 |
| US7498327B2 (en) | 2009-03-03 |
| ECSP067096A (es) | 2007-02-28 |
| NO20070065L (no) | 2007-01-04 |
| PA8637801A1 (es) | 2006-06-02 |
| AU2005258025A1 (en) | 2006-01-05 |
| US20060003945A1 (en) | 2006-01-05 |
| BRPI0512540A (pt) | 2008-03-25 |
| JP2008504267A (ja) | 2008-02-14 |
| EP1758898A1 (en) | 2007-03-07 |
| MX2007000182A (es) | 2007-03-23 |
| IL180198A0 (en) | 2007-06-03 |
| RU2006146923A (ru) | 2008-07-27 |
| TW200606148A (en) | 2006-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20090509A1 (es) | El uso de derivados de benzamida para el tratamiento de transtornos del snc | |
| PE20061353A1 (es) | Compuestos de sulfonamida-tiazolopiridina como activadores de glucocinasa | |
| AR036233A1 (es) | Un compuesto derivado de indol, su uso, procesos para prepararlo y una composicion farmaceutica que lo comprende | |
| EA200500342A1 (ru) | Гетероциклические замещённые пиперазины для лечения шизофрении | |
| AR033379A1 (es) | Compuestos de difenilurea, procedimiento para su preparacion y composiciones farmaceuticas que los contienen | |
| PE20070218A1 (es) | COMPUESTOS DE CICLOALQUILO AMINO-HIDANTOINA Y USO DE ESTOS PARA LA MODULACION DE ß-SECRETASA | |
| PE20070461A1 (es) | Compuestos de amino-5-[4-(difluorometoxi)fenil]-5-fenilimidazolona como inhibidores de b-secretasa | |
| TW200613272A (en) | Isoindolone compounds and their use as metabotropic glutamate receptor potentiators | |
| AR037355A1 (es) | Compuesto derivado de difenilamina, composicion farmaceutica y su uso en la fabricacion de medicamentos | |
| AR064874A1 (es) | Derivados de hexahidro y tetrahidropterinas,composiciones farmaceuticas que los contienen y usos de las mismas en trastornos cardiovasculares y psiquiatricos entre otros | |
| PE20070115A1 (es) | Derivados de [1,3,5]-triazina como inhibidores de aspartil proteasas | |
| AR036057A1 (es) | Compuestos derivados 4-piperazinil indol, su uso, un proceso para prepararlos y composiciones farmaceuticas que los comprenden | |
| MX2010004819A (es) | Derivados de [1h-pirazolo[3,4-b]piridin-4-il]-fenilo o piridin-2-ilo como proteina cinasa c-theta. | |
| TW200720266A (en) | Benzodioxane and benzodioxolan derivatives and uses thereof | |
| AR053748A1 (es) | Entidades quimicas, composiciones y metodos. | |
| BRPI0406762A (pt) | Derivados de n-(1-benzil-2-oxo-2-(1-piperazinil)etil)-1-piperidincarb oxamida e compostos relacionados como antagonistas de cgrp, para tratamento de dores de cabeça | |
| AR039957A1 (es) | Derivados de 1-sulfonil-4-aminoalcoxi indol, metodos de preparacion y composicion farmaceutica | |
| UY24016A1 (es) | Derivados triciclicos del pirazol | |
| ATE438632T1 (de) | Aryl-4-ethinylisoxazolderivate | |
| PE20040772A1 (es) | Composicion y actividad antiviral de derivados de piperazina azaindoloxoaceticos | |
| ATE449082T1 (de) | (3,4-dihydro-chinazolin-2-yl)-(2-aryloxy-ethyl) amine mit aktivität am 5-ht-rezeptor | |
| AR051290A1 (es) | Derivados de hidantoina sustituidas | |
| CO6260069A2 (es) | Tiazolopiridin-2-iloxi-fenil y tiazolopirazin-2-iloxi-fenil aminas como moduladores de la leucotrieno a4 hidrolasa | |
| AR035945A1 (es) | Derivados de piperacina, su uso en la preparacion de medicamentos, procedimiento para la preparacion de dichos compuestos, composiciones farmaceuticas que comprenden dichos compuestos, y metodo para preparar dichas composiciones | |
| PE20040828A1 (es) | Benzoxazinonas como modulares de 5-hidroxitriptamina (5-ht) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FX | Voluntary withdrawal |